How Does GlycanAge Compare to Methylation as a Biomarker for Biological Age?

To learn more about the science behind the GlycanAge® biomarker of biological age and how does it compare to DNA methylation, check this 4 min video by Prof Gordan Lauc, founder of the Genos Glycoscience Research Institute and Director of the Human Glycome Project

By Prof Gordan Lauc, PhD


By Prof Gordan Lauc, PhD

Start or continue your GlycanAge journey

Don’t be afraid to reach out to us and ask questions, provide commentary or suggest topics.

Other articles you may like:

Blog image Glycoscience

CDG Disease: Congenital Disorders of Glycosylation

The glycosylation machinery inside the cell’s factories requires the coordinated action of hundreds of different enzymes working together in perfect harmony. If even one of these enzymes is not working properly, that can be a big problem.

By Mattia Vacchini and Thomas Klarić
Read full article
Blog image Glycoscience

Measure, Normalise, Analyse

Glycans are complex sugar molecules that are present on the majority of proteins in the human body. As such, glycans have shown great potential as biomarkers of both biological and chronological ages, as well as various diseases, including cancer and autoimmune diseases.

By Azra Frkatović
Read full article